Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today
Novo Nordisk is leading the race to get an oral weight loss GLP-1 drug approved. It needs to…
Wall Street rises to its first gain in 4 days
NEW YORK (AP) — U.S. stocks climbed Friday and trimmed their losses for the week after a report…
Big Pharma’s pullback from the UK could have serious side-effects for Ireland – The Irish Times
News from the UK over the past week offers both hope and a cautionary tale for the Irish…
How the ‘Ozempic effect’ is reshaping the global economy
Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
Project delivery PM Group spots slowdown in FDI wave into Ireland – The Irish Times
PM Group, the Tallaght-headquartered international construction project delivery company, has noted a slowdown of foreign direct investment (FDI)…
2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades
The overall stock market keeps reaching new heights, but some of its components are having a lousy year.…
Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets
The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
Weight-loss drugs becoming better value for money, says watchdog
Popular GLP-1 weight-loss injections are now delivering greater value, according to a new report by a leading pharmaceutical…